Summary
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb). These applications will target intermediate size populations of patients living with amyotrophic lateral sclerosis (ALS) who are not eligible for ongoing clinical trials for the prevention, diagnosis, mitigation, treatment, or cure of ALS.
Eligibility
- Small Businesses
- Native American Tribal Governments Federally Recognized
- Private Institutions of Higher Education
- For Profit Organizations Other Than Small Businesses
- County Governments
- Native American Tribal Organizations Other Than Federally Recognized Tribal Governments
- State Governments
- Special District Governments
- Independent School Districts
- Public and Indian Housing Authorities
- Other
- Public and State Institutions of Higher Education
- Nonprofits Non Higher Education Without 501c3
- Nonprofits Having A 501(c)(3) Status With the Irs Other Than Institutions of Higher Education
- City Or Township Governments
Funding categories
- Health
Official source and attribution
This directory republishes federal opportunity information sourced from Simpler.Grants.gov and Grants.gov. Local Business Ranks is not affiliated with or endorsed by the federal government. Always rely on the official opportunity record for application requirements and changes.
Open the official federal record